Cencora マネジメント
マネジメント 基準チェック /24
Cencora's CEO is Bob Mauch, appointed in Oct 2022, has a tenure of 2.08 years. total yearly compensation is $7.70M, comprised of 12.7% salary and 87.3% bonuses, including company stock and options. directly owns 0.012% of the company’s shares, worth €5.24M. The average tenure of the management team and the board of directors is 2.8 years and 9.5 years respectively.
主要情報
Bob Mauch
最高経営責任者
US$7.7m
報酬総額
| CEO給与比率 | 12.7% |
| CEO在任期間 | 2.1yrs |
| CEOの所有権 | 0.01% |
| 経営陣の平均在職期間 | 2.8yrs |
| 取締役会の平均在任期間 | 9.5yrs |
経営陣の近況
Recent updates
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$2b |
| Mar 31 2024 | n/a | n/a | US$2b |
| Dec 31 2023 | n/a | n/a | US$2b |
| Sep 30 2023 | US$8m | US$975k | US$2b |
| Jun 30 2023 | n/a | n/a | US$2b |
| Mar 31 2023 | n/a | n/a | US$2b |
| Dec 31 2022 | n/a | n/a | US$2b |
| Sep 30 2022 | US$6m | US$850k | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | n/a | n/a | US$2b |
| Sep 30 2021 | US$6m | US$800k | US$2b |
| Jun 30 2021 | n/a | n/a | -US$4b |
| Mar 31 2021 | n/a | n/a | -US$4b |
| Dec 31 2020 | n/a | n/a | -US$3b |
| Sep 30 2020 | US$4m | US$700k | -US$3b |
| Jun 30 2020 | n/a | n/a | US$2b |
| Mar 31 2020 | n/a | n/a | US$2b |
| Dec 31 2019 | n/a | n/a | US$649m |
| Sep 30 2019 | US$4m | US$675k | US$855m |
| Jun 30 2019 | n/a | n/a | US$956m |
| Mar 31 2019 | n/a | n/a | US$930m |
| Dec 31 2018 | n/a | n/a | US$1b |
| Sep 30 2018 | US$3m | US$675k | US$2b |
報酬と市場: Bob's total compensation ($USD7.70M) is above average for companies of similar size in the German market ($USD5.20M).
報酬と収益: Bob's compensation has increased by more than 20% in the past year.
CEO（最高経営責任者
Bob Mauch (57 yo)
2.1yrs
在職期間
US$7,697,850
報酬
Dr. Robert P. Mauch, PharmD, Ph D., also known as Bob, is an Executive Vice President at Cencora, Inc. (formerly known as AmerisourceBergen Corporation) since February 2015 and served as its Group Presiden...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman | 13.5yrs | US$17.51m | 0.15% € 61.2m | |
| President | 2.1yrs | US$7.70m | 0.012% € 5.2m | |
| Executive VP & CFO | 6yrs | US$5.45m | 0.058% € 24.5m | |
| Executive VP & Chief Legal Officer | 3.2yrs | US$4.03m | 0.0042% € 1.8m | |
| Senior VP | 12.8yrs | データなし | 0.010% € 4.3m | |
| Senior Vice President of Investor Relations | no data | データなし | データなし | |
| Senior VP & Chief Compliance Officer | no data | データなし | データなし | |
| Executive VP & Chief Human Resources Officer | 5.8yrs | US$3.48m | 0.0056% € 2.4m | |
| EVP & President of U.S. Pharmaceuticals | less than a year | データなし | データなし | |
| Senior VP and Chief Diversity Equity & Inclusion Officer | 2.8yrs | データなし | データなし | |
| EVP & President of International Business Group | less than a year | データなし | データなし | |
| VP & Corporate Treasurer | no data | データなし | データなし |
2.8yrs
平均在職期間
58yo
平均年齢
経験豊富な経営陣: ABG's management team is considered experienced (2.8 years average tenure).
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman | 13.5yrs | US$17.51m | 0.15% € 61.2m | |
| President | less than a year | US$7.70m | 0.012% € 5.2m | |
| Independent Director | 1.1yrs | データなし | データなし | |
| Independent Director | 16.2yrs | US$300.10k | 0.011% € 4.8m | |
| Lead Independent Director | 9.2yrs | US$380.05k | 0.010% € 4.2m | |
| Independent Director | 11.5yrs | US$332.60k | 0.0057% € 2.4m | |
| Independent Director | 14.5yrs | US$320.10k | 0.011% € 4.5m | |
| Independent Director | 4.8yrs | US$375.36k | 0.0044% € 1.9m | |
| Director | 9.8yrs | データなし | データなし | |
| Independent Director | 20yrs | US$320.10k | 0.0077% € 3.2m | |
| Independent director | 2.1yrs | US$397.33k | 0.000090% € 37.9k | |
| Independent Director | 1.8yrs | US$311.82k | 0.00080% € 336.6k |
9.5yrs
平均在職期間
64yo
平均年齢
経験豊富なボード: ABG's board of directors are considered experienced (9.5 years average tenure).